ENDO ONE touts endolaser platform for acne scar remodeling

ENDO ONE SRL is pitching its Italian-made diode endolaser platform as a tool for treating severe atrophic acne scars in aesthetic practice. The company says the system targets tethered rolling and boxcar scars with intralesional laser subcision while aiming to reduce bleeding, downtime and post-inflammatory hyperpigmentation.

Why it matters: - Severe atrophic acne scarring can be difficult to treat because deep fibrotic tethering and dermal volume loss often persist after surface procedures. - ENDO ONE SRL is positioning its endolaser platform as an option for clinicians seeking scar revision with less bruising, shorter recovery and lower pigmentation risk. - The approach is aimed at patients with darker skin tones, where post-inflammatory hyperpigmentation is a major concern.

What happened: - ENDO ONE SRL said its ENDO ONE diode endolaser platform is manufactured in Italy and designed for intralesional laser subcision in acne scar remodeling. - The company said the system uses flexible bare-tip optical micro-fibers placed in the sub-dermal fibrotic plane to release tethering bands and deliver photothermal energy. - ENDO ONE SRL published the discussion on September 22, 2026, in Pozzuoli, Italy. - More information is available through the company's announcement.

The details: - Rolling scars and shallow-to-medium depth boxcar scars are described as the scar types most responsive to subdermal endolaser treatment. - Icepick scars are not presented as a primary indication for intralesional laser subcision because they lack broad horizontal tethering. - The article says icepick tracts are better addressed with focal chemical reconstruction or punch excision. - The platform uses a 400 micrometer bare-tip optical fiber for maneuverability beneath scar beds. - The system uses a 1470 nanometer wavelength to target water in fibrotic tissue and heat the dermal floor to 60–65 degrees Celsius. - The device operates in pulsed or single-pulse mode with pulse widths between 20 and 50 milliseconds. - A 650 nanometer red aiming beam is used to confirm the fiber tip remains under the scar base. - The 980 nanometer wavelength is described as strongly absorbed by hemoglobin and capable of photocoagulating vessels up to one millimeter in diameter. - The company says the laser’s hemostasis reduces intraoperative bleeding, hematoma formation and post-procedural ecchymosis. - The article says most patients see visible scar elevation and texture improvement in one to two sessions. - It says remodeling continues for three to six months after treatment. - The procedure is described as being performed under local infiltration anesthesia using buffered 1% lidocaine with epinephrine. - The article says practices often combine laser subcision with platelet-rich plasma, polynucleotides or hyaluronic acid fillers. - Recovery is described as involving mild swelling and erythema that resolve within 48 to 72 hours. - The article says patients can return to professional routines within two to three days.

Between the lines: - The core pitch is that the platform combines mechanical release and thermal energy in one step, which ENDO ONE SRL presents as more controlled than manual needle subcision. - The emphasis on subdermal energy delivery reflects a strategy to avoid epidermal injury, which is the main driver of pigment complications in resurfacing lasers. - The article frames the device as a workflow fit for aesthetic practices that want scar revision with less downtime and broader skin-type compatibility.

What's next: - ENDO ONE SRL says technical specialists can provide tailored parameter configurations, hands-on training and clinical integration guidance. - The company is directing aesthetic practices and dermatology facilities to request consultations and review technical documentation through its inquiry channel. - Clinics interested in the platform can start with an evaluation session via the company's announcement.

The bottom line: - ENDO ONE SRL is marketing its endolaser system as a targeted alternative to traditional subcision and resurfacing for tethered acne scars, with the main selling points being precision, hemostasis and reduced pigment risk.